AFP and hepatocellular carcinoma: In this regard, Kamimura et al. [28] examined the antitumor effect of a DT-A-expressing plasmid in hepatocellular carcinoma cells (HCC) in vitro and in vivo by using the promoter of alpha-fetoprotein (AFP) for HCC cell-specific gene expression.